Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$11.87 - $15.96 $321,677 - $432,516
-27,100 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$13.87 - $21.04 $34,633 - $52,536
-2,497 Reduced 8.44%
27,100 $376,000
Q4 2020

Feb 02, 2021

SELL
$17.03 - $22.45 $10,218 - $13,470
-600 Reduced 1.99%
29,597 $587,000
Q3 2020

Nov 05, 2020

BUY
$19.3 - $26.92 $582,802 - $812,903
30,197 New
30,197 $691,000

About Akouos, Inc.


  • Ticker AKUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,929,000
  • Description
  • Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...
More about AKUS
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.